Planning & Evaluation Committee

      Loretta G. Que, MD

Loretta G. Que, MD, chair of the ATS Planning and Evaluation Committee, talks about what she and her fellow members are doing to advance the Society’s mission of improving the quality of life of patients with lung diseases, critical illnesses and sleep disorders.

Q. What is the genesis of your committee? When was it established? And what is its charge?

A. We’re one of the original five committees the ATS established in 1905 when the bylaws were first adopted. We review the effectiveness of the Society in accomplishing its vision, mission, and goals, and we report our findings to the Executive Committee. We’re also charged with identifying emerging trends and challenges that have the potential to impact the ability of the ATS to serve our members and the public.

Q. What would you count as your major accomplishments to date?

A. The Planning Committee played a critical leadership role in writing the ATS Vision in 2005 and revising the ATS Mission statement in 2009. Recently, we reviewed the ATS guidelines and statements to identify gaps in new and updated guidelines and statements, and we reported these efforts to the Executive Committee. These recommendations aid the Executive Committee in the selection and funding of future grants and projects.

Q. Having expertise in COPD, asthma, lung cancer evaluation, interstitial lung disease and sarcoidosis, how is the perspective you bring to the table as committee chair unique?

A. At the Duke University Medical Center, I practice general pulmonary and critical care medicine, serve as the program director for the fellowship training program in Pulmonary, Allergy and Critical Care, and run a research laboratory with a focus on nitric oxide signaling in inflammatory lung diseases and development of new strategies and therapies to treat asthma. Drawing upon this background, I’m able to lead with an appreciation and understanding of the importance of clinical practice, education and research. This allows me to encourage discussion within the committee, foster communication, and arrive at consensus for recommendations of societal needs.

Q. Is the make-up of your committee representative of the Society’s membership at large or does it represent a subset of ATS members?

A. Our committee members are representative of the Society’s membership at large and embody the three pillars of the society: pulmonary, critical care and sleep medicine. In addition, our members represent adult and pediatric physicians, academics and clinicians, research scientists, nurses, and the Public Advisory Roundtable (PAR).

Q. What other projects are in the works?

A. We are in the process of revisiting our vision statement to assure that the goals of the ATS continue to reflect the needs of our members and public. We are also evaluating the effectiveness of the organization’s committees in accomplishing their goals, and we’re trying to identify redundancies, potential gaps and deficiencies.

Q. Do you see many opportunities for collaboration with other ATS committees?

A. We bring a different perspective on issues to the table, and we have identified opportunities for collaboration with several committees including Education, Research Advocacy, Documents Development and Implementation, and Membership.

Meet the Members of the ATS Planning & Evaluation Committee
Loretta G. Que (chair)
Graham Nelan (staff)
Dean E. Schraufnagel, MD (ex-officio)
Teresa R. Barnes
Charles L. Daley, MD
Patricia W. Finn, MD
Timothy D. Girard, MD
Michael B. Green, MD
Nicholas S. Hill, MD
Robert Duncan Hite, MD
Monica Kraft, MD
Beth L. Laube, PhD
Lynda A. Mackin, PhD, ANP
Susanna A. McColley, MD
Judith Neubauer PhD
David R. Park, MD
James A. Rowley, MD
William D. Travis, MD
Carolyn H. Welsh, MD
Christine H. Wendt, MD